
### [NCIT:C7574](http://purl.obolibrary.org/obo/NCIT_C7574)
**Label:** Prostate Phyllodes Tumor

**Subclasses:** [NCIT:C5532](http://purl.obolibrary.org/obo/NCIT_C5532) (Benign Prostate Phyllodes Tumor), [NCIT:C5531](http://purl.obolibrary.org/obo/NCIT_C5531) (Malignant Prostate Phyllodes Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C61539](http://purl.obolibrary.org/obo/NCIT_C61539) (Malignant Glandular Epithelium Resembling the Normal Endometrium Present) 53.85%
- [NCIT:C41457](http://purl.obolibrary.org/obo/NCIT_C41457) (Well-Circumscribed Lesion) 53.85%
- [NCIT:C61466](http://purl.obolibrary.org/obo/NCIT_C61466) (Malignant Component Present) and [NCIT:C61541](http://purl.obolibrary.org/obo/NCIT_C61541) (Atypical Glandular Epithelium Resembling the Normal Endometrium Present) 53.85%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and [NCIT:C61542](http://purl.obolibrary.org/obo/NCIT_C61542) (Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) 53.85%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and [NCIT:C61541](http://purl.obolibrary.org/obo/NCIT_C61541) (Atypical Glandular Epithelium Resembling the Normal Endometrium Present) 53.85%
- Thing 52.89%
- [NCIT:C53596](http://purl.obolibrary.org/obo/NCIT_C53596) (Epithelial Component Present) 39.32%
- [NCIT:C61541](http://purl.obolibrary.org/obo/NCIT_C61541) (Atypical Glandular Epithelium Resembling the Normal Endometrium Present) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 39.20%
- [NCIT:C54172](http://purl.obolibrary.org/obo/NCIT_C54172) (Carcinomatous Component Present) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 39.20%


